← All candidates
9 insider filings on record.
9 filings on record.
ASPNASPEN AEROGELS INC
NYSE · Basic Materials · $407.47M
$4.91
-0.21% · Sep 15
9 insider filings on record.
None of them an open-market buy in the last year.
Price · 1Y · daily● 1 sell
▸ hover a marker for the filing · drag to zoom · daily bars sharpen to 30-min on close ranges · 4 moves explained
AI brief · from the filings on this pagePro
The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.
Market cap
$407.47M
Float
76.8M
92% public
Short % float
Pro
Price / profit
—
not yet profitable
Price / future profit
—
Price / sales
2.0
Institutional stakes
▸ a holder crossing 5% files Schedule 13D if they intend to act on the company, 13G if they certify they will not · /A amends an earlier filing
1 filingnewest first
The record
newest first
DateTypeInsiderOf stakeShares @ priceValue
4 more transactions on Pro →Context
Wall St
$7.75 avg target
+57.8% vs today · 5 analysts
▸ relayed analyst opinion, which tends to run optimistic — not our forecast or advice
Earnings · EPS vs forecast
0 of 4 quarters beat
Q2 '26−$0.22 act−$0.02
Q1 '26−$0.28 act−$0.02
Q4 '25−$0.34 act−$0.12
Q3 '25−$0.06 act−$0.06
Coverage
Aspen Aerogels (ASPN) Stock Sees Fair Value Lift After Q2 Improves Segment VisibilitySimply Wall St. · 08-09Aspen Aerogels Q2 Earnings Call HighlightsMarketBeat · 08-07Aspen Aerogels Inc (ASPN) (Q2 2026) Earnings Call Highlights: Strong Q3 Outlook and European ...GuruFocus.com · 08-06Aspen Aerogels (ASPN) Reports Q2 Loss, Beats Revenue EstimatesZacks · 08-06
The file stays open
9 filings on record.
The next one will be too.
▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice